Cargando…

Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study

Detalles Bibliográficos
Autor principal:	Park, Jeong-Yeol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593221/ https://www.ncbi.nlm.nih.gov/pubmed/33078601 http://dx.doi.org/10.3802/jgo.2020.31.e96

Ejemplares similares

Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
por: Falcone, Francesca, et al.
Publicado: (2020)

Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2021)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review
por: Giampaolino, Pierluigi, et al.
Publicado: (2022)

Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium
por: Phan, Ngoc T.H., et al.
Publicado: (2023)

Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium
por: Phan, Ngoc T.H., et al.
Publicado: (2023)

Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword
por: Park, Jeong-Yeol
Publicado: (2017)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Fertility-sparing treatment in women with endometrial cancer
por: Won, Seyeon, et al.
Publicado: (2020)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study
por: Ayhan, Ali, et al.
Publicado: (2018)

Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review
por: Schuurman, Teska, et al.
Publicado: (2021)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
por: Moss, Haley A., et al.
Publicado: (2014)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique
por: Catena, U, et al.
Publicado: (2023)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls
por: Kesterson, Joshua P., et al.
Publicado: (2012)

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer
por: Stewart, Katherine Ikard, et al.
Publicado: (2020)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study
por: Casablanca, Yovanni, et al.
Publicado: (2022)

Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2021)

Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes
por: Mutlu, Levent, et al.
Publicado: (2022)

Fertility-sparing treatment for patients with endometrial carcinoma
por: Ind, T
Publicado: (2023)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Long-term survival of endometrioid endometrial cancer patients
por: Gottwald, Leszek, et al.
Publicado: (2010)

Tumor grade and chemotherapy response in endometrioid endometrial cancer
por: Davidson, Brittany A., et al.
Publicado: (2016)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer
por: Zmarzły, Nikola, et al.
Publicado: (2022)

Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
por: Fu, Hung-Chun, et al.
Publicado: (2018)

Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer
por: Jiang, Wei, et al.
Publicado: (2017)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
por: Obermair, Andreas, et al.
Publicado: (2020)

Fertility-Sparing Methods in Adolescents Affected by Endometrial Cancer: A Comprehensive Review
por: Gałczyński, Krzysztof, et al.
Publicado: (2021)

Effect of bariatric surgery on endometrial cancer regression as part of fertility sparing treatment
por: Lin, Jinlin, et al.
Publicado: (2023)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
por: Contreras, Nayanar-Adela, et al.
Publicado: (2022)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
por: Zou, Jing, et al.
Publicado: (2012)

Impact of genomic stability on protein expression in endometrioid endometrial cancer
por: Lomnytska, M I, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qlq2g8dse0kusemb7oqi1r1a97